Business  /  Published 16.02.22

Two Cipla promoters sell shares

Two promoters of Cipla Ltd on Tuesday divested shares worth over Rs 1,835.6 crore in the firm, through open market transactions. This represents 2.5 per cent of the total shareholding of the comp...
By PTI in New Delhi

Business  /  Published 05.02.22

Cipla CFO Upadhye quits

Drug major Cipla, which is not new to churn in its top deck, on Friday saw another exit when its global chief financial officer Kedar Upadhye resigned. In 2020, Nikhil Chopra, the chief executive of ...
By Our Special Correspondent in Mumbai

India  /  Published 29.12.21

Nod for drug and two new vaccines

India has added two new vaccines and an early-use anti-viral drug to its armoury to fight Covid-19, all three products based on core technologies developed in the US but produced in India. The Centra...
By G.S. Mudur in New Delhi

Opinion  /  Published 07.08.21

Eye on England: portrait honour for Cipla boss

Calcutta should avoid London’s mistake of allowing too many basement structures because there is nowhere for the water to escape after heavy rains. Last month, London had two flash floods which ...
By Amit Roy

Business  /  Published 15.05.21

Cipla net rises 73%

Engineering and construction giant Larsen & Toubro (L&T) on Friday reported an 11.3 per cent rise in consolidated net profit at Rs 3,820.16 crore for the March quarter of 2020-21 on the back o...
By Our Bureau in Mumbai


Business  /  Published 11.05.21

Eli Lilly in pact with trio for drug

Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with three Indian pharmaceutical firms — Sun Pharma, Cipla and Lupin — to expedite the availability of its ...
By Our Special Correspondent in Mumbai

India  /  Published 07.05.21

Covid: Govt nod to new treatment

By G.S. Mudur in New Delhi

Business  /  Published 04.08.20

Top-level exits at Cipla

Pharmaceutical major Cipla has seen three major exits that include  Nikhil Chopra, CEO of its India business, Nikhil Lalwani, who led its US business, and Kunal Khanna, head of the chronic and em...
By Our Special Correspondent in Mumbai

World  /  Published 09.11.18

Cambridge nod to Yusuf Hamied

The 1702 chair in chemistry at Cambridge is being renamed after Yusuf Hamied, head of the Indian pharmaceutical firm Cipla, the university has announced.“The chair will now be known as the Yusuf Ham...
By Amit Roy in London

World  /  Published 02.04.20

Vaccine test on humans ‘in six months’

When a vaccine for coronavirus is developed, companies in India will be manufacturing it both for the domestic market and for the world, according to Dr Yusuf Hamied, chairman of the pharma giant Cipl...
By Amit Roy in London


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.